{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:29Z","timestamp":1787032769413,"version":"build-2736575974"},"reference-count":39,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. La toxina botul\u00ednica se destaca por sus m\u00faltiples aplicaciones terap\u00e9uticas; tiene m\u00e1s de 30 indicaciones reconocidas en distintas especialidades. Sin embargo, a pesar de los estudios realizados en Latinoam\u00e9rica, no hay una caracterizaci\u00f3n integral sobre su amplio espectro de uso cl\u00ednico.Objetivo. Clasificar el uso farmacoterap\u00e9utico de la toxina botul\u00ednica en un centro de salud p\u00fablico de Bogot\u00e1, para identificar los riesgos de interacciones farmacol\u00f3gicas con otros compuestos y las posibles barreras para su uso. Se pretende fomentar una mejor comprensi\u00f3n de las indicaciones, pr\u00e1cticas y regulaciones de la toxina botul\u00ednica en el contexto colombiano.Materiales y m\u00e9todos. Se realiz\u00f3 un estudio transversal en el que se analiz\u00f3 la administraci\u00f3n de la toxina botul\u00ednica mediante la metodolog\u00eda de prescripci\u00f3n-indicaci\u00f3n. Se recopil\u00f3 informaci\u00f3n de las historias cl\u00ednicas y del sistema de prescripci\u00f3n electr\u00f3nica \u201cMi prescripci\u00f3n\u201d. Para el an\u00e1lisis de los datos, se utiliz\u00f3 el software estad\u00edstico JAMOVI, versi\u00f3n 2.2.5.Resultados. De 197 pacientes tratados con la toxina botul\u00ednica, la mayor\u00eda de las prescripciones se registraron bajo la categor\u00eda de trastornos neurol\u00f3gicos (70,6 %), aunque la indicaci\u00f3n m\u00e1s frecuente correspondi\u00f3 a alteraciones de la articulaci\u00f3n temporomandibular (18,8 %). En ni\u00f1os, la indicaci\u00f3n predominante fue la par\u00e1lisis cerebral esp\u00e1stica (90 %). El 92,4 % de las aplicaciones cl\u00ednicas coincidieron con las aprobadas por el Instituto Nacional de Vigilancia de Medicamentos y Alimentos de Colombia. Se identificaron riesgos de interacciones farmacol\u00f3gicas en el 30,9 % de los casos, asociadas significativamente con una carga anticolin\u00e9rgica (p &lt; 0,001).Conclusi\u00f3n. La toxina botul\u00ednica es ampliamente utilizada en Colombia debido a sus diversas indicaciones cl\u00ednicas. En general, se encontr\u00f3 una buena correspondencia entre las prescripciones y las recomendaciones de las gu\u00edas reguladoras. Es crucial evaluar los antecedentes farmacol\u00f3gicos de los pacientes para minimizar el riesgo de interacciones farmacol\u00f3gicas. Se subraya la necesidad de revisar y ajustar la normativa sobre el uso de la toxina botul\u00ednica en el pa\u00eds.<\/jats:p>","DOI":"10.7705\/biomedica.7383","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T18:50:07Z","timestamp":1755283807000},"page":"390-405","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Tratamiento con toxina botul\u00ednica en un entorno de recursos limitados: experiencias de una instituci\u00f3n p\u00fablica","Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country"],"prefix":"10.7705","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0211-3025","authenticated-orcid":false,"given":"Gloria Andrea","family":"Panesso","sequence":"first","affiliation":[{"name":"Departamento de Farmacolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia; Departamento de Farmacolog\u00eda Cl\u00ednica, Fundaci\u00f3n Universitaria de Ciencias de la Salud, Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-7633","authenticated-orcid":false,"given":"Juan Diego","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-0805","authenticated-orcid":false,"given":"Annelise","family":"Velasco","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-8034","authenticated-orcid":false,"given":"Stefan\u00eda","family":"Forero","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-518X","authenticated-orcid":false,"given":"Daniel","family":"Perdomo","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2287-658X","authenticated-orcid":false,"given":"\u00c1ngela","family":"Villamil","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-0850","authenticated-orcid":false,"given":"Edna Roc\u00edo","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-5165","authenticated-orcid":false,"given":"Claudio Alejandro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Unidad de Servicios de Salud Sim\u00f3n Bol\u00edvar, Subred Integrada de Servicios de Salud Norte E. S. E., Bogot\u00e1, D. C., Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"150661","doi-asserted-by":"crossref","unstructured":"1. Choudhury S, Baker MR, Chatterjee S, Kumar H. Botulinum toxin: An update on pharmacology and newer products in development. Toxins. 2021;13:58. https:\/\/doi.org\/10.3390\/toxins13010058","DOI":"10.3390\/toxins13010058"},{"key":"150662","doi-asserted-by":"crossref","unstructured":"2. Dressler D. Botulinum toxin drugs: Brief history and outlook. J Neural Transm. 2016;123:277-9. https:\/\/doi.org\/10.1007\/s00702-015-1478-1","DOI":"10.1007\/s00702-015-1478-1"},{"key":"150663","doi-asserted-by":"crossref","unstructured":"3. Bach K, Simman R. The multispecialty toxin: A literature review of botulinum toxin. Plast Reconstr Surg Glob Open. 2022;10:e4228. https:\/\/doi.org\/10.1097\/GOX.0000000000004228","DOI":"10.1097\/GOX.0000000000004228"},{"key":"150664","doi-asserted-by":"crossref","unstructured":"4. Dressler D, Johnson EA. Botulinum toxin therapy: Past, present and future developments. J Neural Transm (Vienna). 2022;129:829-33. https:\/\/doi.org\/10.1007\/s00702-022-02494-5","DOI":"10.1007\/s00702-022-02494-5"},{"key":"150665","doi-asserted-by":"crossref","unstructured":"5. Egeo G, Fofi L, Barbanti P. Botulinum neurotoxin for the treatment of neuropathic pain. Front Neurol. 2020;11. https:\/\/doi.org\/10.3389\/fneur.2020.00716","DOI":"10.3389\/fneur.2020.00716"},{"key":"150666","unstructured":"6. Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima). Direcci\u00f3n de Medicamentos y Productos Biol\u00f3gicos. Sistema de Tr\u00e1mites en L\u00ednea - Consultas P\u00fablicas. Fecha de consulta:13 de junio de 2023. Disponible en: https:\/\/consultaregistro.invima.gov.co\/Consultas\/consultas\/consreg_encabcum.jsp"},{"key":"150667","unstructured":"7. Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima). [Oficina virtual]. Fecha de consulta:13 de junio de 2023. Disponible en: https:\/\/app.invima.gov.co\/ovirtual\/"},{"key":"150668","unstructured":"8. Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima). Alerta sanitaria: 174-2023. Fecha de consulta:13 de junio de 2023. Disponible en: https:\/\/app.invima.gov.co\/alertas\/ckfinder\/userfiles\/files\/ALERTAS%20SANITARIAS\/medicamentos_pbiologicos\/2023\/Junio\/Alerta%20sanitaria_174-2023_TOXINAS%20BOTULI%CC%81NICAS.pdf"},{"key":"150669","doi-asserted-by":"crossref","unstructured":"9. Alster TS, Harrison IS. Alternative clinical indications of botulinum toxin. Am J Clin Dermatol. 2020;21:855-80. https:\/\/doi.org\/10.1007\/s40257-020-00532-0","DOI":"10.1007\/s40257-020-00532-0"},{"key":"150670","unstructured":"10. Padda IS, Tadi P. Botulinum toxin. In: StatPearls. StatPearls Publishing; 2023. Fecha de consulta: 29 de agosto de 2024. Disponible en: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557387"},{"key":"150671","unstructured":"11. Botero C, Carlos J, R\u00edos G, Felipe J. Inyecci\u00f3n de toxina botul\u00ednica en pacientes con disinergia detrusor-esf\u00ednter en quienes han fallado otros tratamientos. Urol Colomb. 2009;8:19-26."},{"key":"150672","unstructured":"12. Valencia DV, Mendoza A. Experiencia en el manejo de toxina botul\u00ednica de 500 unidades en ni\u00f1os con par\u00e1lisis cerebral. Rev Col Med Fis Rehab. 2012;22:129-41."},{"key":"150673","unstructured":"13. Moreno L\u00f3pez CL, Cerquera Cleves C, Moreno L\u00f3pez CL, Cerquera Cleves C. Toxina botul\u00ednica en el manejo de las diston\u00edas. Acta Neurol Colomb. 2017;33:32-7."},{"key":"150674","doi-asserted-by":"crossref","unstructured":"14. Figueredo De P\u00e9rez DA, Vargas Chaves I, Figueredo De P\u00e9rez DA, Vargas Chaves I. El acceso a medicamentos en Colombia y los contornos de un derecho y una pol\u00edtica farmac\u00e9utica a medio camino. Justicia. 2020;25:125-50.","DOI":"10.17081\/just.25.37.3528"},{"key":"150675","unstructured":"15. Ministerio de Salud y Protecci\u00f3n Social de Colombia. Abec\u00e9 MIPRES. Fecha de consulta: 13 de junio de 2023. Disponible en: https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/VP\/AF\/abece-ctc-reporte-prescripcion.pdf"},{"key":"150676","unstructured":"16. World Health Organization Collaborating Center. The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) index. Fecha de consulta: 13 de junio de 2023. Disponible en: https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"150677","unstructured":"17. Lexicomp\u00ae Drug Interactions \u2013 UpToDate. Fecha de consulta: 13 de junio de 2023. Disponible en: https:\/\/doctorabad.com\/UpToDate\/d\/di.htm"},{"key":"150678","unstructured":"18. ACB calculator. Fecha de consulta: 13 de junio de 2023. Disponible en: https:\/\/www.acbcalc.com\/"},{"key":"150679","doi-asserted-by":"crossref","unstructured":"19. deSilva B, Crenshaw D, Matrka L, Forrest LA. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder. Laryngoscope. 2019;129:808-11. https:\/\/doi.org\/10.1002\/lary.27471","DOI":"10.1002\/lary.27471"},{"key":"150680","doi-asserted-by":"crossref","unstructured":"20. King A, Quirouet A, Moore CK. Urologic applications of botulinum toxin. Cleve Clin J Med. 2015;82:456-64. https:\/\/doi.org\/10.3949\/ccjm.82a.13166","DOI":"10.3949\/ccjm.82a.13166"},{"key":"150681","unstructured":"21. Otero W, Serrano C, Hani A. Respuesta terap\u00e9utica con toxina botul\u00ednica de la acalasia en nuestro medio. Rev Colomb Gastroenterol. 2002;17:56-60."},{"key":"150682","doi-asserted-by":"crossref","unstructured":"22. Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol. 2012;15:325-36. https:\/\/doi.org\/10.1016\/j.mib.2012.05.012","DOI":"10.1016\/j.mib.2012.05.012"},{"key":"150683","doi-asserted-by":"crossref","unstructured":"23. Finzi E. Botulinum toxin treatment for depression: A new paradigm for psychiatry. Toxins. 2023;15:336. https:\/\/doi.org\/10.3390\/toxins15050336","DOI":"10.3390\/toxins15050336"},{"key":"150684","doi-asserted-by":"crossref","unstructured":"24. Kruger THC, Wollmer MA. Depression\u2013An emerging indication for botulinum toxin treatment. Toxicon. 2015;107(Pt A):154-7. https:\/\/doi.org\/10.1016\/j.toxicon.2015.09.035","DOI":"10.1016\/j.toxicon.2015.09.035"},{"key":"150685","doi-asserted-by":"crossref","unstructured":"25. Viegas FG, Figueiredo I, Ferreira F, Louren\u00e7o A. Use of botulinum toxin type A in psychiatry - New perspectives and future potential. Eur Psychiatry. 2021;64(Suppl. 1):S480. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.1283","DOI":"10.1192\/j.eurpsy.2021.1283"},{"key":"150686","doi-asserted-by":"crossref","unstructured":"26. Ahsanuddin S, Roy S, Nasser W, Povolotskiy R, Paskhover B. Adverse events associated with botox as reported in a food and drug administration database. Aesthet Plast Surg. 2021;45:1201-9. https:\/\/doi.org\/10.1007\/s00266-020-02027-z","DOI":"10.1007\/s00266-020-02027-z"},{"key":"150687","doi-asserted-by":"crossref","unstructured":"27. Patil S, Willett O, Thompkins T, Hermann R, Ramanathan S, Cornett EM, et al. Botulinum toxin: Pharmacology and therapeutic roles in pain states. Curr Pain Headache Rep. 2016;20:15. https:\/\/doi.org\/10.1007\/s11916-016-0545-0","DOI":"10.1007\/s11916-016-0545-0"},{"key":"150688","doi-asserted-by":"crossref","unstructured":"28. Corridan P, Nightingale S, Mashoudi N, Williams AC. Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol. 1990;74:309-10. https:\/\/doi.org\/10.1136\/bjo.74.5.309","DOI":"10.1136\/bjo.74.5.309"},{"key":"150689","unstructured":"29. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Centro de Informaci\u00f3n de Medicamentos Veterinarios (CIMAVet). Ficha t\u00e9cnica b\u00f3tox 100 unidades Allergan, polvo para soluci\u00f3n inyectable. Fecha de consulta: 14 de junio de 2023. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/63194\/FT_63194.html"},{"key":"150690","doi-asserted-by":"crossref","unstructured":"30. Machado-Duque ME, Casta\u00f1o-Montoya JP, Medina-Morales DA, Castro-Rodr\u00edguez A, Gonz\u00e1lez-Montoya A, Machado-Alba JE. Drugs with anticholinergic potential and risk of falls with hip fracture in the elderly patients: A case-control study. J Geriatr Psych Neur. 2018;31:63-9. https:\/\/doi.org\/10.1177\/0891988718757370","DOI":"10.1177\/0891988718757370"},{"key":"150691","doi-asserted-by":"crossref","unstructured":"31. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477-83. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03491.x","DOI":"10.1111\/j.1532-5415.2011.03491.x"},{"key":"150692","doi-asserted-by":"crossref","unstructured":"32. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med. 2015;175:401-7. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663","DOI":"10.1001\/jamainternmed.2014.7663"},{"key":"150693","doi-asserted-by":"crossref","unstructured":"33. Dan\u00e9s I, Agust\u00ed A, Vallano A, Alerany C, Mart\u00ednez J, Bosch JA, et al. Outcomes of offlabel drug uses in hospitals: A multicentric prospective study. Eur J Clin Pharmacol. 2014;70:1385-93. https:\/\/doi.org\/10.1007\/s00228-014-1746-2","DOI":"10.1007\/s00228-014-1746-2"},{"key":"150694","doi-asserted-by":"crossref","unstructured":"34. Doan TN, Kuo MY, Chou LW. Efficacy and optimal dose of botulinum toxin A in poststroke lower extremity spasticity: A systematic review and meta-analysis. Toxins (Basel). 2021;13:428. https:\/\/doi.org\/10.3390\/toxins13060428","DOI":"10.3390\/toxins13060428"},{"key":"150695","doi-asserted-by":"crossref","unstructured":"35. Restrepo-Zea JH, Casas-Bustamante LP, Espinal-Piedrahita JJ. Cobertura universal y acceso efectivo a los servicios de salud: \u00bfQu\u00e9 ha pasado en Colombia despu\u00e9s de diez a\u00f1os de la Sentencia T-760? Rev Salud P\u00fablica. 2020;20:670-6.","DOI":"10.15446\/rsap.v20n6.78585"},{"key":"150696","doi-asserted-by":"crossref","unstructured":"36. Hern\u00e1ndez JMR, Rubiano DPR, Barona JCC. Barreras de acceso administrativo a los servicios de salud en poblaci\u00f3n colombiana, 2013. Ci\u00eanc Sa\u00fade Colet. 2015;20:1947-58.","DOI":"10.1590\/1413-81232015206.12122014"},{"key":"150697","doi-asserted-by":"crossref","unstructured":"37. Agudelo-Londo\u00f1o SM, Maldonado Casta\u00f1eda OJ, Restrepo O. Cuerpos de datos y tecnolog\u00edas de derechos: haciendo derecho a la salud en Colombia a trav\u00e9s del aplicativo web MIPRES para la prescripci\u00f3n de tecnolog\u00edas de alto costo. In: Casas R, P\u00e9rez-Bustos T, editores. Ciencia, tecnolog\u00eda y sociedad en Am\u00e9rica Latina: la mirada de las nuevas generaciones. Buenos Aires: Rosalba Casas y Tania Cristina P\u00e9rez-Bustos; 2021. Fecha de consulta: 27 de junio de 2023. p. 259-80. Disponible en: http:\/\/biblioteca.clacso.edu.ar\/clacso\/gt\/20190905052402\/Ciencia_tecnologia_sociedad.pdf","DOI":"10.2307\/j.ctvt6rmtj.13"},{"key":"150698","unstructured":"38. Ministerio de Salud y Protecci\u00f3n Social. Resoluci\u00f3n 2808 de 2022. Fecha de consulta: 27 de junio de 2023. p. 259-80. Disponible en: https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%20No.%202808%20de%202022.pdf"},{"key":"150699","doi-asserted-by":"crossref","unstructured":"39. Organizaci\u00f3n Panamericana de la Salud. La COVID-19 y la prestaci\u00f3n de servicios de salud esenciales en el primer nivel de atenci\u00f3n - S\u00edntesis de evidencia. Fecha de consulta: 29 de agosto de 2024. Disponible en: https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/57768\/OPSPHECPICOVID19230013_spa.pdf?sequence=1&isAllowed=y","DOI":"10.26633\/RPSP.2024.51"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7383\/5713","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7383\/5861","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7383\/5713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:46:04Z","timestamp":1773265564000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,11]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7383","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"2025-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}